Our findings indicated that TGF-β signaling induced EMT in GCB-resistant bladder cancer cells by activating Smad2/3, thereby upregulating Slug and ZEB2 and ultimately reducing hENT1 and hCNT1, the major influx transporters of GCB [14,18]. This evidence concerns the gene SMAD2 and urinary bladder carcinoma.